ruxolitinib
incyte,morphosys,novartis,abbvie,bms
['rux,(-crux),(-trux),(-deruxtecan)', 'rux,(-crux),(-trux)', 'morphosys', 'bmsnews', 'abbvie', 'incyte', 'bms']
interesting early data suggestive of synergism on the bms beti added to rux in 1l and to fedr in 2l presented at #eha23 by haifa kathrin al-ali. multiple betis following the lead of pelabresib! 
Associate Professor, Leukemia at MD Anderson; myeloproliferative neoplasm expert, NCCN panelist. Tweets reflect my own views; not necessarily my institution's.